Obesity is a disease with severe health consequences and increased risk of mortality. The most commonly used criteria to assess the presence and the severity of obesity are body mass index, waist circumference, waist-to-height ratio and the presence of the health conditions caused or worsened by obesity. Worldwide obesity has more than doubled in the last 4 decades. Obesity is the second of the leading preventable causes of death worldwide (after smoking). Obesity has a plurifactorial pathogenesis. The central perturbation consists in the imbalance between calories intake and calories consumption (by inappropriate diet and sedentary lifestyle). Identification of all the ethiological factors is important for treatment and prophylaxis. Weight loss benefits are multiple and important: improvement in glicemic control and in plasma lipid levels, blood presure control, obstructiv sleep apneea reduction, improvement in management of daily activities and profesional performances, increase quality of life, reduction in mortality. Overweight or obese patient will complete a diagnostic and a treatment program. Treatment of obesity claims a targeted multidimensional therapy: weight and lifestyle management, diet, sustained physical activity in daily life, exercise, decrease life stressors, smoking cessation, drug therapy, bariatric surgery psichological, familial and social suport. Weight loss program must be carefully planned, adapted to the patient's abilities and comorbidities and supervised by a nutritionist and a physiotherapist.
Background
Nowadays obesity is considered a chronic disease being also a severe individual health condition and an important public health problem. Obesity is due to an excess of body fat accumulation which leads to severe health consequences and a significant percentage of mortality [1] . Most often obesity is defined by "Body Mass Index" (BMI). BMI is a measuring tool for assessing obesity based on individual's weight and height. BMI does not actually measure the percentage of body fat but is still used as a standard measure of obesity and a simple criteria to indicate the need of lifestyle changes, medical or surgical interventions against obesity. The World Health Organization (WHO) established the values for obesity definition based on BMI [1] :
• Underweight (BMI ≤ 18.5)
• Normal weight (BMI 18.5 -24.9)
• Overweight (BMI 25.0 -29.9)
• Obesity (BMI 30.0 -34.9) or Class I obesity • Severe obesity (BMI 35.0 -39.9) or Class II obesity • Morbid obesity (BMI ≥ 40.0) or Class III obesity BMI is not always an accurate predictor of body fat or fat distribution, particularly in muscular individuals because of the existent differences of fat and muscle proportion and distribution. Other instruments to describe obesity, fat distribution, cardiovascular risk and mortality are: waist circumference (WC), waist-to-height ratio (WHtR) and waist-to-hip ratio (WHR) [1, 2] . WHtR is considered the best prospective indicator of cardiovascular risk as demonstrated several cross-sectional studies [3, 4, 5] . The American Heart Association recommended 102 cm for men and 88 cm for women as cutoff levels for WC, and 0.95 for men and 0.88 for women as cutoff levels for WHR [6, 7] .
Epidemiology of obesity

Morbidity:
• Worldwide obesity has more than doubled in the last 4 decades [8] • Age and gender differences in food intake and weight gain have been identified with an increase in adolescence, peaking in the second decade after which it declines [33] ; • The decline in sex steroid levels occurring in the perimenopause results in an increase in visceral fat and an increased risk of the metabolic syndrome development. Women are at higher risk for more severe obesity at menopause [14, 32] ; • Most excess weight before puberty is gained before 5 years of age. Weight at 5 years of age bears little relation to birth weight but closely predicts weight at 9 years of age and future metabolic risk [33] . Most likely an obese child will become an obese adult [13] .
Environmental factors
Environmental factors are the prime causes of modern obesity. The fact that obesity has increased dramatically in the last decades appears to disconsider genetics as a major main cause.
• Nutrient imbalance (beetween intake and energy consumtion) is playing the key role [1, 6, 8, 10] : -The high food intake, especially the amount of fat -Low energy expenditure, sedentary lifestyle, low physical activity -Family influence in lifestyle (especially for obese children) • The type of eaten food -"Obesogenic environment". The high-fat/high-sugar food produces addiction to food similar to drug abuse by dopamine deficiency. Studies with positron emission tomography (PET) have shown that exposure to high-fat diet over a number of weeks caused a reduction in Dopamin2Receptors and a dysfunction in the reward capacity. The result is over-eating to compensate the dopamine deficiency [34] ;
Disregulation in Central Nervous System
Disregulation in Central Nervous System (hypothalamus + limbic system) in processing the peripheral and central signals concerning appetite, satiety. Emotional and social problems (stigmatization) [24] • Disregulation occurs in the homeostatic control of eating (hypothalamic level) and in the hedonic system (pleasure of eating) located in the limbic system leading to overeating and obesity [35] .
• Stress, depression, low self-esteem, insufficient sleep, mental illness [10] ;
Endocrinologic disorders
Endocrinologic disorders (hypothyroidism, Cushing's syndrome, testosterone deficiency, polycystic ovarian syndrome, insulinoma, hypothalamic lesions and genetic syndromes) often present with obesity. The fat cell is considered an endocrine organ that produces several peptides that participate in the regulation of adipocyte function [36] ;
6. Other conditions:
• Smoking cessation;
• Pregnancy at an advanced maternal age, which may cause susceptibility to obesity in children [27] ; • Retirement conditions [10] .
Obesity management strategies
The increasing number of individuals with obesity and the multiple negative consequences of obesity have increased the medical attention for prophylaxis and development of safe and efficacious treatment strategies. Multidimensional pathogenesis of obesity claims a careful and targeted multidimensional therapy. Obesity and its related comorbidities are largely preventable. Weight loss (WL) benefits are multiple and important [6, 7, 8, 10, 37, 38, 39] :
• Improvement in glicemic control, Overweight or obese patients will be included in a complete diagnostic and treatment program which will contain:
• The weight control program must be individually customized to the patient in order to achieve a desirable outcome.
Dietary changes for weight loss
Diet programs in obesity treatment include slow weight loss (WL) and than maintaining the WL like a permanent preoccupation and part of a person's lifestyle. Success rates of long-term WL maintenance are low, ranging from 2-20% [39] . Diet program characteristics [10] :
• Diet has to establish individual realistic goals (5 -10% WL) • Diet must be individualized to the patient for long term weight control [24] • Diet should fit the needs of the patient • A diet should be natural and easy to follow: three main meals daily, plus one or two snacks • Important diet details: -limit energy intake from total fats; -increase consumption of fruit and vegetables, as well as legumes, whole grains and nuts; -limit the intake of sugar and avoid alcohol use.
• Self-monitoring diet under supervision of a nutritionist (follow up) [24] : -Monitoring the WL minimum 3 months -if unsuccesfull WL at 3 months (< 5%) → repeat firstline advice → control at 6 months -if unsuccessfull WL at 6 months → dietetitian reassesment and consider pharmacotherapy -successfull WL (> 5% at 3 months and > 10% at 6 months) → maintenance phase with control (monthly reassessments) The basic principle which must take into account in any diet is that WL depends on caloric deficit and caloric deficit depends on total calories, not on the type of calories consumed compared to calories. The diet must have a conventional distribution: carbohydrates 55% of total calories, fat 30% and protein 15-20% of total calories [37] .
Traditional methods: low-calories diets" 800-1,500 cal. a day
• Low fat (the total daily fat limit should be 40 grams; the total daily saturated fat limit would be 13 gramms -10% calories from fat) • High fiber diet 20 to 30 g/day • Under 6 g of sodium chloride/day • Provide 0,25 -0.75 kg of fat loss/week • Long-term healthy diet → low fat, high complex carbohydrate, rich in vegetable fibers New methods: "Very Low-calories diets" [41] • For short-term WL (BMI > 30)
• Prepared formulas of 800 cal or less which replace all usual food intake • Provide 1.5 to 2.5 kg of fat loss/week, for a total WL of 22 kg over 12 weeks • Not appropriate for children or adolescents
Increased activity and exercise
Increased physical activity and regular exercise are considered a desirable complement to dieting and they have the added benefit of improving other parameters, such as followed [11] :
• Increase energetic expenditure • Fat loss (especially visceral fat)
• Attenuation of muscle mass loss, developing muscle mass and increasing muscle tone • Increase thermogenetic response and the basal metabolism (BM) • Increase insulin sensibility, improve lipids profile • Decrease hypertention • Psychological benefit Exercise program must be carefully planned, adapted to the patient's abilities and physical condition and at least the initial few weeks supervised by a physiotherapist. In 2008, in US were launched the "Physical activity guidelines for adults" which stipulate the effective program of organized exercise as adjunct in combating obesity [7] . The main recommendations are:
• Avoid inactivity, increase daily activities • Regular exercise: -At least 150-300 min (2,5 h -5 h) a week of moderate-intensity or 75 -150 min (1,15 h -2,3 h) a week of vigorous-intensity aerobic physical activity; -Muscle-strengthening activities which involve all major muscle groups; -Continuation of physical activity for at least two years from the start of the WL intervention will enhance the maintenance of the WL.
Drug therapy for weight loss
The inadequate efficacy of exercise and diet especially in severe obese individuals coupled with their poor long-term success has focused research efforts on other strategies, including pharmacotherapy and bariatric surgery [23] . Despite of intensive researches there are few drugs approved for treating obesity. The main drugs used are described in table II [22, 23, 38] . Pharmacological targets for obesity treatment consist of multiple targets and include:
• Inhibition of appetite (sibutramine)
• Inhibition of fat absorption (orlistat)
• Weight-regulatory brain circuits (cannabinoid receptor-1 (CB1) antagonists) • Metabolism stimulation (CB1 antagonists; drugs that stimulate uncoupling proteins). Choosing the correct WL therapy depends on many factors: long-term safety experience, WL capability, drugs side-effects, patient comorbidities. Drug combinationassociation of 2 or more WL medication -improves outcomes and total WL.
Drug therapy for WL is limited by contraindications, adverse effects and high costs (Sibutramine was retired in 2010 because of cardiovascular risk). Recommandation of the "Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity" is very specific "Drugs that induce weight loss approved by FDA may be used only as part of a weight loss program including diet and physical activity for patients with BMI> 30 without concomitant diseases or risk factors due to obesity and for patients with BMI = 27 to the disease or risk factors due to obesity. Drugs will never be used without concomitant lifestyle modification. It is necessary to continue evaluating the efficacy and safety in drug therapy management. If drugs are useful in achieving or maintaining weigh loss and its adverse effects are minor they can be used, if not drugs will be discontinued" [23] .
Bariatric Surgery
Bariatric surgery (BS) is now considered the most efficacious treatment for reducing excess body weight. The gastrointestinal tract is transformed by surgery until decreases intraluminal capacity for food. This can be achieved using the gastric banding technique (using an implanted medical device), the sleeve gastrectomy or biliopancreatic diversion with duodenal switch (including removal of a portion of the stomach) or using gastric bypass surgery, by resecting and re-routing the small intestine to a small stomach puch [17, 42, 43] .
The predominantly restrictive procedures (vertical banded gastroplasty, sleeve gastrectomy, gastric banding) reduce the stomach size in order to limit the gstric volume, promote early satiety and thus reduce the oral intake. These techniques leave the alimentary canal in continuity and do not lead to food malabsorption [12] .
The predominantly malabsorptive procedures (biliopancreatic diversion, endo-luminal sleeve) and the mixed procedures (gastric bypass surgery, sleeve gastrectomy with duodenal switch) by re-routing of food away from much of the small intestine to partially prevent absorption of food [12, 43, 44] .
The degree of WL achieved by BS is significantly higher than other treatment measures and the WL is long-lasting in the majority of the subjects [45] .
Overall, patients undergoing BS showed many benefits:
• Reduction of appetite and significant WL • Reduction in the severity of symptoms of diabetes [46, 47] • Improvement in cardiovascular risk factors, control of hypertension • Improvement in mobility • Return of fertility • Significant improvement in OSA (any decrease with 15 kg/m 2 in BMI associates a decrease with 36 OSA events/h in the apneea/hypopneea index) • Significant improvement in quality of life • Decrease in mortality [45] The responsible mechanisms for the decreased appetite and remission of diabetes are unknown, but probably include some combination of enhanced nutrient stimulation of the distal intestine and consequent enhanced release of incretin hormones (GLP-1), reduced stimulation of the proximal intestine [47] . Bariatric Surgery should be considered as a treatment option for patients with:
• 
